MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF


                              OPERATIONS OF aSTRA

The following discussion and analysis of the financial condition and results of
operations of Astra Space, Inc. should be read together with our audited
consolidated financial statements as of and for the years ended December 31,
2020 and 2019 and unaudited interim condensed consolidated financial statements
as of and for the three and nine months ended September 30, 2021 and 2020,
together with related notes thereto. This discussion may contain forward-looking
statements based upon current expectations that involve risks and uncertainties.
Our actual results may differ materially from those projected in these
forward-looking statements as a result of various factors, including those set
forth under "Risk Factors". Certain amounts may not foot due to rounding. Unless
the context otherwise requires, all references in this section to "the Company"
"Astra," "us," "our" or "we" refer to Astra Space, Inc. prior to the Business
Combination, and to New Astra following the consummation of the Business
Combination on June 30, 2021.

Overview



Our mission is to launch a new generation of space services to improve life on
Earth. These services are enabled by new constellations of small satellites in
Low Earth Orbit ("LEO"), which have rapidly become smaller, cheaper, and more
numerous than legacy satellites. Launch vehicles, however, have not evolved in
the same way - most rockets remain focused on serving legacy satellites and
human spaceflight missions. As a result, we believe most existing launch
vehicles are too large, expensive, infrequently launched, and insufficiently
responsive to meet the needs of the evolving space market.

We aim to solve this problem with the world's first mass-produced orbital launch
system. Our system consists of a small launch vehicle and mobile ground
infrastructure that can fit inside standard shipping containers for rapid
deployment anywhere in the world. Our rocket requires a launch site with little
more than a concrete pad and only six Astra employees on-site, leveraging our
highly automated launch operations, and our production system is designed to
scale efficiently to hundreds of launches per year. Our rocket's payload
capacity is tailored for the needs of modern LEO satellite constellations,
allowing precise and rapid placement of individual satellites into their
required orbits. We believe this makes Astra's system more responsive and
affordable than other launch alternatives, for thousands of LEO satellites
planned in the coming decade.

While our primary focus remains the growth and development of our launch
services business, we continue to develop other product and service offerings to
support our overall mission to Improve Life on Earth from Space. On November 4,
2021, we announced the filing of an application with the Federal Communications
Commission for V-band spectrum access, which, if approved, would allow us to
offer a satellite constellation in the future.

Holicity Business Combination and Public Company Costs



We entered into a business combination agreement with Holicity Inc. ("Holicity")
on February 2, 2021. On June 30, 2021 (the "Closing Date"), the previously
announced business combination was consummated. Upon the consummation of the
business combination, Holicity Merger Sub Inc. ("Merger Sub"), a wholly owned
subsidiary of Holicity, merged with and into Astra with Astra surviving the
merger as a wholly owned subsidiary of Holicity (the "Business Combination").
Astra became a wholly owned subsidiary of Holicity, which renamed to Astra
Space, Inc. ("New Astra"), and Astra renamed to Astra Space Operations, Inc.
upon the consummation of the Business Combination.

The Business Combination was accounted for as a reverse recapitalization. Astra
was the predecessor and New Astra is the successor SEC registrant, meaning that
Astra's financial statements for previous periods will be presented in New
Astra's future periodic reports filed with the SEC. Holicity was treated as the
acquired company for financial statement reporting purposes.

The most significant change in the post-combination Company's reported financial
position and results was a net increase in cash of $463.6 million. We paid $25.2
million in transaction costs relating to the Business Combination at the
closing. We recorded a liability related to the Public and Private Placement
Warrants of $56.8 million in the condensed consolidated balance sheet on Closing
Date.

As a consequence of the Business Combination, the Company trades under the ticker symbol "ASTR" on the Nasdaq. We anticipate that we will need to hire additional personnel and implement procedures and processes to address public company regulatory requirements and customary practices. We expect to incur additional annual expenses as a public company for, among other things, directors' and officers' liability insurance, director fees and additional internal and external accounting and legal and administrative resources, including increased audit and legal fees.

COVID-19 Impact



On March 11, 2020, the World Health Organization declared the novel strain of
coronavirus ("COVID-19") a global pandemic and recommended containment and
mitigation measures worldwide. The extent of the impact of the coronavirus
pandemic on Astra's operational and financial performance will depend on various
future developments, including the duration and spread of the outbreak

                                       37

--------------------------------------------------------------------------------


and impact on its customers, suppliers, and employees, all of which is uncertain
at this time. Astra expects the COVID-19 pandemic to adversely impact revenue
and results of operations, but Astra is unable to predict at this time the size
and duration of this adverse impact. Astra has seen some signs of positive
effects for its long-term business prospects and partnerships as a result of the
pandemic. The COVID-19 pandemic has created an even greater need for broadband
internet access from anywhere in the world, and businesses are thinking
differently about how their workforce can stay connected. There have also been
recent government and commercial announcements about continuous investments in
this area and we believe this will continue to support the growth of the small
satellite market for the foreseeable future.

For more information on Astra's operations and risks related to health epidemics, including the COVID-19 pandemic, please see the section entitled "Risk Factors."

Key Factors Affecting Our Results and Prospects



We believe that our performance and future success depend on a number of factors
that present significant opportunities for us but also pose risks and
challenges, including competition from better known and well-capitalized
companies, the risk of actual or perceived safety issues and their consequences
for our reputation and the other factors discussed under "Risk Factors." We
believe the factors discussed below are key to our success.

Commencing and Expanding Commercial Launch Operations



We are on track to monthly production of our launch vehicles, with a goal of
reaching a regular launch cadence in the future. When we refer to a "commercial
launch," we mean a launch conducted under an FAA commercial launch license. With
binding agreements for over 50 launches (as of September 30, 2021), our
contracted revenue is significant, and we are in active discussions with
numerous potential customers, including government agencies and private
satellite companies, to add to our contracted revenue.

In December 2020, we successfully launched Rocket 3.2 to an altitude of 380 km,
demonstrating orbital launch capability. We improved propellant depletion
controls to address the findings from the December 2020 flight. In August 2021,
we launched Rocket LV0006 of which engine was aborted. During liftoff, fuel and
liquid oxygen leaked from the propellant supply system attached to the rocket.
The leaked propellants mixed and ignited, which disabled one of the five
first-stage engines. We analyzed the cause of the anomaly and implemented
certain design changes to avoid having this issue in future. Prior to commencing
commercial launches, we must secure launch licenses with the Federal Aviation
Administration (FAA). On August 18, 2021, the FAA issued us a license to launch
the current version of our launch vehicle (Rocket 3) from our spaceport in
Kodiak, Alaska through March 9, 2026. Any delays in commencing our commercial
launch operations, including due to delays or cost overruns in obtaining FAA
licenses or other regulatory approvals for future versions of our launch
vehicles or at future spaceports, could adversely impact our results and growth
plans.

Lowering Manufacturing Costs and Increasing Payloads



We aim to be the most cost-efficient dedicated orbital launch system provider.
We plan to increase the maximum payload capability of our rockets from
approximately 50 kg for our first commercial flight to up to 500 kg for a
mid-inclination 500 km orbit, which we believe will make Astra a compelling
option for low Earth orbit constellation deployment and replenishment. Our
affordable manufacturing processes use normally readily available materials and
are highly scalable, while we believe our ongoing improvements in design and
manufacturing will further reduce our per rocket manufacturing costs. We have
invested approximately $19.3 million in our manufacturing facility through
September 30, 2021 and we expect the facility will be at full capacity by the
end of 2024, which we believe will enable us to increase the pace of launch
vehicle construction and our launch cadence. While we believe that our estimate
is reliable, the development of our manufacturing facility may take longer than
planned, including due to delays in obtaining federal and state regulatory
approvals of our final construction plans or any changes that are required to be
made to those plans. Any delays in our achieving full manufacturing capacity
could adversely impact our results and growth plans.

Expand Our Space Products and Services Offerings



We are in the preliminary stages of developing our Space Services offering
(which we previously referred to as "Satellite Services"), providing a modular
configurable satellite buses for customers, leveraging both in-house and
partner-provided subsystem components and in-house design and integration
services, as well as operational support of satellites on orbit, to turn-key
provision of entire constellations, offering "concept to constellation" in
months instead of years. Specifically, our Space Services encompass all aspects
of hosted satellite and constellation services, including hosting customer
payloads onto our satellites, and delivering services, such as communication and
other services, to customers from our space platform. These services are
expected to allow customers to focus on developing innovative payloads rather
than having to design or develop complete satellite buses or satellites or
constellations, which we will provide, along with ancillary services that are
likely to include telemetry, tracking and control ("TT&C"), communications,
processing, as well as software development and maintenance.

                                       38

--------------------------------------------------------------------------------

On November 4, 2021, we filed an application with the Federal Communication Commission, under which we requested authority to launch and operate a non-geostationary orbit satellite system using V-band frequencies (the "Constellation") as we work to build out our Space Services offering to enable communications.



We also expect to launch our Spaceport Services offering, which may provide
turn-key spaceports with the capability to launch Astra rockets or contracting
launch services through these spaceports. We envision that our spaceports will
require minimal on-site infrastructure, will leverage our highly automated
launch operations and can be installed for an initial cost of between
approximately $10 million and $20 million. We anticipate this offering will lead
to important additional opportunities, such as providing launch services for
customers, both government and commercial, interested in launching out of a
specific locale. We expect to make significant investments in our Space Services
and Spaceport Services programs. Although we believe that our financial
resources, including the proceeds of the Business Combination and the related
private placement, will be sufficient to meet our capital needs, our timeline
and budgeted costs for these offerings are subject to substantial uncertainty,
including due to compliance requirements of U.S. federal export control laws and
applicable foreign and local regulations, the impact of political and economic
conditions, and, particularly in the case of our anticipated Spaceport offering,
the need to identify opportunities and negotiate long-term agreements with
customers for these services, among other factors. Please see the section
entitled "Risk Factors".

Acquisition of Apollo Fusion



On July 1, 2021, the Company completed its acquisition of Apollo Fusion, Inc.
("Apollo"), a designer and builder of thruster propulsion systems for satellite
programs. The acquisition-date fair value of the consideration transferred
totaled $75.4 million, net of cash acquired, consisting of approximately
2,558,744 shares of the Company's Class A common stock worth $33.0 million which
was determined based on the closing market price of the Company's common stock
on the acquisition date, $19.9 million in cash and $23.0 million of the fair
value of contingent consideration. The contingent consideration arrangement
requires the Company to pay up to $75.0 million payable in $15.0 million of cash
and $60.0 million of the Company's Class A common stock, at a reference price
per share equal to the then volume weighted average trading price over a
five-day trading period prior to the business day prior to issuance, provided
certain customer revenue-based milestones are achieved prior to December 31,
2023.

In addition, an additional $10.0 million of cash ("Cash Payment") and options to
purchase shares of the Company's Class A Common Stock, having a value of $10.0
million ("Incentive Shares"), at a reference price per share equal to the then
volume weighted average trading price over a five day trading period prior to
the business day prior to issuance, will be issued or issuable to employees of
Apollo that join Astra, subject to certain performance-based milestones and
other vesting provisions. This consideration is accounted for as compensation
expense over the requisite service period in the post-acquisition period as the
cash payment and vesting of Incentive Shares is subject to continued employment
with the company until the satisfaction of certain performance-based milestones
and other vesting provisions. As of September 30, 2021, no Incentive Shares were
granted to employees of Apollo that joined the Company subsequent to the
acquisition as certain key terms and conditions of the Incentive Shares were not
finalized. The Company assessed the probability of success of performance
milestones related to the Cash Payment and determined that it is probable that
certain milestones will be met. Therefore, the Company recognized $1.4 million
compensation costs which was included in research and development expense for
the three months and nine months ended September 30, 2021 and $1.4 million was
accrued in accrued expenses and other current liabilities as of September 30,
2021.

Key Components of Results of Operations



We are an early-stage company and our historical results may not be indicative
of our future results for reasons that may be difficult to anticipate.
Accordingly, the drivers of our future financial results, as well as the
components of such results, may not be comparable to our historical or future
results of operations.

Revenues

We have not generated any revenue to date. Following the commercial launch of
our services, we expect to generate a significant portion of our revenues in
Launch Services from delivering payloads into orbit. We also expect to generate
revenues by providing design and delivery of propulsion systems, Space Services
and Spaceport Services to our customers. Over time, we expect Space Services to
grow more quickly and to represent a significant portion of our revenues beyond
2025.

Expenses

Research and Development Expense



Our research and development expenses consist primarily of internal and external
expenses incurred in connection with our research activities and development
programs. These expenses include, but are not limited to, development supplies,
testing materials, personnel costs (including salaries and benefits),
depreciation expense, overhead allocation, (consisting of various support and
facility costs), stock-based compensation and consulting fees. Research and
development costs are expensed as incurred.

                                       39

--------------------------------------------------------------------------------


We allocate research and development costs by function rather than by project,
as a significant majority of our historical research and development spending
was related to the initial development and testing of our underlying technology,
including preparation for multiple test launches.

Our current primary research and development objectives focus on the development
and finalization of our offerings. The successful development of these offerings
involves many uncertainties, including:

?
timing in finalizing launch and space systems design and specifications;
?
successful completion of analyses and ground test programs to validate that new
or changed designs perform as expected;
?
successful completion of flight test programs, including flight safety tests;
?
our ability to obtain additional applicable approvals, licenses or
certifications from regulatory agencies, if required, and maintaining current
approvals, licenses or certifications;
?
performance of our manufacturing facilities despite risks that disrupt
productions, such as natural disasters and hazardous materials;
?
performance of a limited number of suppliers for certain raw materials and
components;
?
performance of our third-party contractors that support our research and
development activities;
?
our ability to maintain rights from third parties for intellectual properties
critical to research and development activities; and
?
our ability to continue funding and maintain our current research and
development activities.

A change in the outcome of any of these variables could delay the development of
our rockets, which in turn could impact when we are able to commercialize our
offerings.

As we are currently still in our final development and testing stage of our
launch services, we have expensed all research and development costs associated
with developing and building our launch services offering. We expect that our
research and development expenses will increase in the short-term as we invest
in improving and further reducing the costs of our launch system as well as
developing and improving our Space Services offering.

Sales and Marketing Expense



Sales and marketing expenses consist of personnel and personnel-related
expenses, including stock-based compensation for our business development team
as well as advertising and marketing expenses. We expect to increase our sales
and marketing activities in order to grow our customer base and increase market
share. We also expect that our sales and marketing expenses will increase over
time as we continue to hire additional personnel to scale the business. We did
not begin incurring sales and marketing expenses until 2021.

General and Administrative Expense



General and administrative expenses consist primarily of personnel-related costs
(including salaries, bonuses, benefits, and stock-based compensation expense)
for personnel in executive, finance, accounting, corporate development and other
administrative functions. General and administrative expenses also include legal
fees, professional fees paid for accounting, auditing, consulting, tax, and
investor relations services, insurance costs, and facility costs not otherwise
included in research and development expenses and costs associated with
compliance with the rules and regulations of the SEC and the stock exchange.

Income Tax (Benefit) Expense

Our income tax provision consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in the tax law. We maintain a valuation allowance against the full value of our U.S. and state net deferred tax assets because we believe the recoverability of the tax assets is not more likely than not.


                                       40

--------------------------------------------------------------------------------

Results of Operations



Comparison of the Three Months and Nine Months Ended September 30, 2021 and 2020



                         Three Months Ended            Period over              Nine Months Ended              Period over
                            September 30,             period change               September 30,               period change
(in thousands,
except percentages)       2021          2020          ($)         (%)           2021          2020           ($)          (%)
Operating expenses:
Research and
development            $   21,724     $  5,423     $  16,301        301 %   

44,159 20,955 $ 23,204 111 % Sales and marketing 1,090

            -         1,090       n.m.           2,229             -          2,229       n.m.
General and
administrative             19,730        2,358        17,372        737          50,712         9,341         41,371        443
Total operating
expenses                  (42,544 )     (7,781 )     (34,763 )      447    

(97,100 ) (30,296 ) (66,804 ) 221 Loss from operations (42,544 ) (7,781 ) (34,763 ) 447

(97,100 ) (30,296 ) (66,804 ) 221 Interest (expense) income, net

                    18       (1,312 )       1,330       (101 )   

(1,194 ) (3,564 ) 2,370 (66 ) Other income, net 25,895 3,891 22,004 566

          25,177         7,852         17,325        221
Loss on
extinguishment of
  convertible notes             -            -             -       n.m.        (131,908 )           -       (131,908 )     n.m.
Loss on
extinguishment of
  convertible notes
attributable
  to related parties            -            -             -       n.m.          (1,875 )           -         (1,875 )     n.m.
Loss before taxes         (16,631 )     (5,202 )     (11,429 )      220        (206,900 )     (26,008 )     (180,892 )      696
Income tax (benefit)
expense                      (383 )          -          (383 )     n.m.            (383 )           -           (383 )     n.m.
Net loss               $  (16,248 )   $ (5,202 )   $ (11,046 )      212 %    $ (206,517 )   $ (26,008 )   $ (180,509 )      694 %


____________

n.m. = not meaningful.

Research and Development

Research and development costs were $21.7 million for the three months September
30, 2021, compared to $5.4 million for the three months ended September 30,
2020. The $16.3 million increase mainly reflected a $9.8 million increase in
personnel-related costs and recruiting expenses for personnel in research and
development departments, a $1.3 million increase in stock compensation expense,
a $1.7 million increase in research and development materials expense, a $1.6
million increase in Technology licensed and software subscription licenses
related expenses, a $0.7 million increase in depreciation and amortization
expense with the remainder due to changes in freight and other research and
development related expenses.

Research and development costs were $44.2 million for the nine months September
30, 2021, compared to $21.0 million for the nine months ended September 30,
2020. The $23.2 million increase mainly reflected a $12.4 million increase in
personnel-related costs and recruiting expenses for personnel in research and
development departments, a $4.4 million increase in stock compensation expense,
a $2.4 million increase in research and development materials expense, a $1.8
million increase in Technology licensed and software subscription licenses
related expenses and a $1.0 million increase in depreciation and amortization
expense with the remainder due to changes in freight and other research and
development expenses.

Sales and Marketing

Sales and Marketing expenses were $1.1 million for the three months ended September 30, 2021. There were no sales and marketing expenses in the three months ended September 30, 2020 as the Company was primarily focused on research and development activities.



Sales and Marketing expenses were $2.2 million for the nine months ended
September 30, 2021. There were no sales and marketing expenses in the nine
months ended September 30, 2020 as the Company was primarily focused on research
and development activities. The sales and marketing expenses primarily consists
of personnel-related costs and consulting charges.

General and Administrative



General and administrative expenses were $19.7 million for the three months
ended September 30, 2021, compared to $2.4 million for the three months ended
September 30, 2020. The $17.4 million increase was primarily due to a $5.7
million increase in employee-related costs, a $1.3 million increase in
stock-based compensation expense, a $3.1 million increase from transaction costs
incurred and expensed by the Company in relation to the Apollo Merger, a $1.5
million increase in third-party consulting and recruitment costs, a $2.1 million
increase in accounting and legal related expenses, a $1.7 million increase in
insurance related expenses with the remainder due to changes in facilities
costs, software subscription fees and other general and administrative related
expenses.

General and administrative expenses were $50.7 million for the nine months ended
September 30, 2021, compared to $9.3 million for the nine months ended September
30, 2020. The $41.4 million increase was primarily due to a $15.4 million
increase in stock-based

                                       41

--------------------------------------------------------------------------------


compensation expense, a $6.2 million increase from transaction costs incurred
and expensed by the Company in relation to the business combination and Apollo
Merger, a $7.9 million increase in employee costs, a $4.2 million increase in
third-party consulting and recruitment costs, a $3.1 million increase in
accounting, audit and legal related fees, a $1.8 million increase in insurance
related expenses and a $1.5 million increase in facility and rent, with the
remainder due to changes in facilities costs, IT equipment fees, and software
subscription fees.

Interest (Expense) Income, Net



There was no interest expense for the three months ended September 30, 2021,
compared to $1.3 million for the three months ended September 30, 2020. The $1.3
million decrease in interest expense was primarily due to the settlement of
convertible notes on January 28, 2021, therefore we incurred no interest expense
related to convertible notes for three months ended September 30, 2021 while we
incurred $1.3 million interest expense related to convertible notes for three
months ended September 30, 2020.

Interest expense, net was $1.2 million for the nine months ended September 30,
2021, compared to $3.6 million for the nine months ended September 30, 2020. The
$2.3 million decrease in interest expense was primarily due to the settlement of
convertible notes on January 28, 2021, therefore we incurred $0.5 million and
$3.5 million interest expense related to convertible notes for nine months ended
September 30, 2021 and 2020, respectively, offset by an increase of $0.6 million
in interest expense related to Bridge Loan and SVB loan for nine months ended
September 30, 2021.

Other Income, Net

Other income, net was $25.9 million for the three months ended September 30,
2021, compared to $3.9 million for the three months ended September 30, 2020.
The $22.0 million increase in other income was primarily due to a $20.4 million
in income from change in fair value of warrant liability, a $4.9 million in
income from a gain on forgiveness of PPP Note and a $0.6 million in income from
government research and development contracts for the three months ended
September 30, 2021 offset by a $2.6 million in income from a gain on the mark to
market derivative liability related to convertible notes and a $1.2 million in
income from government research and development contracts for the three months
ended September 30, 2020. The remaining $0.1 million was due to other
nonrecurring income for three months ended September 30, 2021.

Other income, net was $25.2 million for the nine months ended September 30,
2021, compared to $7.9 million for the nine months ended September 30, 2020. The
$17.3 million increase in other income was primarily due to a $20.4 million in
income from change in fair value of warrant liability, a $4.9 million in income
from a gain on forgiveness of PPP Note and a $0.6 million in income from
government research and development contracts for the nine months ended
September 30, 2021 offset by $0.8 million due to a nonrecurring payment to one
of our investors for the nine months ended September 30, 2021 and a $5.4 million
in income from a gain on the mark to market derivative liability related to
convertible notes and a $2.2 million in income from government's research and
development contracts for the nine months ended September 30, 2020.

Loss on Extinguishment of Convertible Notes

There was no such loss for the three months ended September 30, 2021 and 2020.



Loss on extinguishment of convertible notes of $131.9 million for the nine
months ended September 30, 2021 was due to the settlement of convertible notes
on January 28, 2021. There was no such loss for the nine months ended September
30, 2020.

Loss on Extinguishment of Convertible Notes Attributable to Related Parties

There was no such loss for the three months ended September 30, 2021 and 2020.



Loss on extinguishment of convertible notes attributable to related parties of
$1.9 million for the nine months ended September 30, 2021 was due to the
settlement of convertible notes attributable to related parties on January 28,
2021. There was no such loss for the nine months ended September 30, 2020.

Income Tax (Benefit) Expense

We recorded an income tax benefit of $0.4 million as the result of Apollo acquisition for the three months and nine months ended September 30, 2021. We did not incur income tax expense for the three months and nine months ended September 30, 2020.

Adjustment to redemption value on Convertible Preferred Stock

There was no adjustment to redemption value on Convertible Preferred Stock for the three months ended September 30, 2021 and 2020.


                                       42

--------------------------------------------------------------------------------


Adjustment to redemption value on Convertible Preferred Stock of $1,011.7
million for the nine months ended September 30, 2021, was due to the
remeasurement of Convertible Preferred Stock to its redemption value due to the
likelihood of a redemption event becoming probable. There was no such adjustment
for the nine months ended September 30, 2020.

Liquidity and Capital Resources

Liquidity



We measure liquidity in terms of our ability to fund the cash requirements of
our research and development activities and our current business operations,
including our capital expenditure needs, contractual obligations and other
commitments. Our current liquidity needs relate to research and development
activities, mainly in connection with the ongoing development of our rocket
technology, lease obligations and capital expenditures, which primarily relate
to the development of our manufacturing facility.

We had $378.7 million in cash and cash equivalents as of September 30, 2021
(compared to $10.6 million as of December 31, 2020). We had no debt as of
September 30, 2021 (compared to $71.1 million as of December 31, 2020, of which
$59.8 million represented outstanding principal on the Company's convertible
notes). On January 28, 2021, we settled the outstanding convertible notes into
convertible preferred shares as part of the Series C financing, from which we
also received $30.0 million in cash proceeds. In June 2021, we closed the
Business Combination and private placement, from which we received $463.6
million in net cash proceeds. We believe our operating cash flows, together with
our cash on hand and the net proceeds from the Business Combination and the
related private placement will be sufficient to meet our working capital and
capital expenditure requirements for a period of at least twelve months from the
date of these financial statements.

While we expect to begin generating positive cash flows from our operating
activities in 2024 (based on our anticipated Launch Services offering only), we
may need additional cash due to changing business conditions or other
developments, including unanticipated regulatory developments and competitive
pressures.

Summary Statement of Cash Flows for the Nine Months Ended September 30, 2021 and 2020

The following table sets forth the primary sources and uses of cash and cash equivalents for the periods presented below:





                                        Nine months ended September 30,            Period over Period Change
(in thousands)                            2021                   2020                 $                   %
Net cash used in operating
activities                          $        (79,576 )     $        (24,896 )   $      (54,680 )             220 %
Net cash used in investing
activities                                   (41,280 )               (2,223 )          (39,057 )           1,757
Net cash provided by financing
activities                                   488,897                 21,850            467,047             2,138
Net increase (decrease) in cash
and cash equivalents and
restricted cash                     $        368,041       $         (5,269 )   $      373,310             (7085 )%



Cash Flows used in Operating Activities



For the nine months ended September 30, 2021, net cash used in operating
activities was $79.6 million. The primary factors affecting the Company's
operating cash flows during this period were net loss of $206.5 million and a
non-cash gain of $20.4 million due to change in fair value of warrant liability
and $4.9 million due to a gain on forgiveness of PPP Note, offset by non-cash
charges including a non-cash loss on extinguishment of convertible notes of
$133.8 million, stock-based compensation expense of $20.5 million, depreciation
and amortization expense of $3.9 million, and amortization of convertible note
debt discounts of $0.4 million. Changes in operating working capital items
primarily reflect the increase in inventories of $4.2 million, prepaid and other
current assets of $13.9 million, accounts payable of $1.3 million, accrued
expenses and other current liabilities of $11.3 million and decrease in other
non-current liabilities of $0.2 million.

For the nine months ended September 30, 2020, net cash used in operating
activities was $24.9 million, which was comprised of net loss of $26.0 million
and a non-cash gain on mark to market derivatives of $5.4 million, offset by
non-cash charges including stock-based compensation expense of $0.6 million,
depreciation expense of $2.5 million, and amortization of convertible note debt
discounts of $2.7 million. Changes in operating working capital items primarily
reflect the increase in accrued expenses and other current liabilities of $1.6
million and decreases in accounts payable of $0.7 million.

Cash Flows used in Investing Activities



For the nine months ended September 30, 2021, net cash used in investing
activities was $41.3 million, which was comprised mainly of cash paid as
purchase price consideration in the acquisition of Apollo Fusion, Inc., net of
cash acquired of $19.4 million, acquisition of an indefinite-lived intangible
trademark asset of $3.2 million and purchases of property, plant and equipment
of $18.7 million.

                                       43

--------------------------------------------------------------------------------


For the nine months ended September 30, 2020, net cash used in investing
activities was $2.2 million, which was comprised mainly of purchases of tooling
equipment, manufacturing equipment and furniture and fixtures of $1.0 million
and leasehold improvements of $1.2 million.

Cash Flows from Financing Activities



For the nine months ended September 30, 2021, net cash provided by financing
activities amounted to $488.9 million and consisted primarily of proceeds from
the Business Combination and private offering, net of transaction costs, of
$463.6 million, proceeds from the issuance of Series C of $30.0 million and
borrowings of $10.0 million, proceeds from the issuance of stock under equity
plans of $1.8 million, offset by repayments on borrowings of $16.4 million.

For the nine months ended September 30, 2020, net cash provided by financing
activities amounted to $21.9 million and consisted primarily of proceeds from
the issuance of convertible notes of $17.9 million and borrowings of $5.4
million, partially offset by repayments on borrowings of $1.4 million.

Commitments and Contractual Obligations

We are a party to operating leases primarily for land and buildings (e.g., office buildings, manufacturing and testing facilities and spaceport) and certain equipment (e.g., copiers) under non-cancellable operating leases. The following table summarizes our lease commitments as of September 30, 2021:





                                                             Minimum Lease
Year Ending December 31                                       Commitment
                                                            (in thousands)
2021 (excluding the nine months ended September 30, 2021)   $           458
2022                                                                  1,761
2023                                                                  1,655
2024                                                                  1,655
2025                                                                  1,655
Thereafter                                                            4,481
Total future undiscounted minimum lease payments            $        11,665
Less: Imputed Interest                                               (2,486 )
Total reported lease liability                              $         9,179




On May 25, 2021, the Company entered a contract with a supplier to purchase
components. The Company is obligated to purchase $22.5 million of components
over 60 months. The Company may terminate the supply agreement by paying 50% of
the remaining purchase commitment at any point during the contract term. No
purchases were made under the contract for the three months ended September 30,
2021. For the nine months ended September 30, 2021, the Company made total
purchases of $0.4 million.

Apart from the aforementioned leases and purchase commitments, we do not have any other material contractual obligations, commitments or contingent obligations.

Off-Balance Sheet Arrangements



As of September 30, 2021, we did not have any off-balance sheet arrangements, as
defined in the rules and regulations of SEC Regulation S-K, such as the use of
unconsolidated subsidiaries, structured finance, special purpose entities or
variable interest entities.

Critical Accounting Policies and Estimates



Our consolidated financial statements have been prepared in accordance with U.S.
generally accepted accounting principles, or U.S. GAAP. Preparation of the
financial statements requires our management to make a number of judgments,
estimates and assumptions relating to the reported amount of expenses, assets
and liabilities and the disclosure of contingent assets and liabilities. We
consider an accounting judgment, estimate or assumption to be critical when (1)
the estimate or assumption is complex in nature or requires a high degree of
judgment and (2) the use of different judgments, estimates and assumptions could
have a material impact on our consolidated financial statements. Our significant
accounting policies are described in Note 2 to our consolidated financial
statements included elsewhere in this quarterly report on Form 10-Q. Our
critical accounting policies are described below.

Research and Development



We conduct research and development activities to develop existing and future
technologies that advance our space platform offerings towards
commercialization. Research and development activities include basic research,
applied research, concept formulation studies, design, development, and related
test program activities. Costs incurred for developing our spaceflight system
and flight profiles

                                       44

--------------------------------------------------------------------------------


primarily include equipment, material, and labor hours used for development and
testing. Costs incurred for performing ground tests and test flights primarily
include rocket or spacecraft components, propellants and other consumables,
shipping and transport costs, shipping and transport costs, and payroll and
benefits for employees and ground crew. Research and development costs also
include rent, maintenance, and depreciation of facilities and equipment and
other allocated overhead expenses. We expense all research and development costs
as incurred.

Stock-Based Compensation

We recognize compensation expense for time-based restricted stock units ("RSUs")
using the straight-line amortization method based on the fair value of RSUs on
the date of grant. The fair value of RSUs is the closing market price of Astra
common stock on the date of grant. We recognize compensation expense for
time-based stock options and employee stock purchase plan rights under the 2021
Employee Stock Purchase Plan, based on the estimated grant-date fair value
determined using the Black-Scholes valuation model with a straight-line
amortization method. We determine the fair value of stock options, which is
impacted by the following assumptions:

?
Expected Term - We use the midpoint between the vesting term and the original
contractual term (contractual period to exercise). If the option contains graded
vesting, then the vesting term is based on the vesting pattern.
?
Expected Volatility - The volatility is based on a benchmark of comparable
companies.
?
Expected Dividend Yield - The dividend rate used is zero as we have never paid
any cash dividends on common stock and do not anticipate doing so in the
foreseeable future.
?
Risk-Free Interest Rate - The interest rates used are based on the implied yield
available on U.S. Treasury zero-coupon issues with an equivalent remaining term
equal to the expected life of the award.

Certain equity awards include service, market and performance conditions ("Performance-based awards"). The fair value of Performance-based awards is estimated on the date of grant using the Monte Carlo simulation technique. Compensation expense for Performance-based awards is amortized based upon a graded vesting method over the requisite service period.

We reverse previously recognized costs for unvested options in the period that forfeitures occur.



Income Taxes

We follow the asset and liability method of accounting for income taxes under
ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for
the expected future tax consequences of temporary differences between
consolidated financial statement carrying amounts and the tax basis of assets
and liabilities and net operating loss and tax credit carryforwards. Valuation
allowances are established when necessary to reduce deferred tax assets to the
amount expected to be realized.

We determine whether it is more likely than not that a tax position will be
sustained upon examination. If it is not more likely than not that a position
will be sustained, no amount of benefit attributable to the position is
recognized. The tax benefit to be recognized for any tax position that meets the
more likely than not recognition threshold is calculated as the largest amount
that is more than 50% likely of being realized upon resolution of the
contingency. Changes in recognition or measurement are reflected in the period
in which judgment occurs.

Our policy is to include interest and penalties related to the underpayment of
income taxes as a component of the provision for income taxes. To date, there
have been no interest or penalties recorded in relation to unrecognized tax
benefits.

Derivative Instruments



We recognize all derivative instruments as either assets or liabilities in the
balance sheet at their respective fair values. We evaluate our debt and equity
issuances to determine if those contracts or embedded components of those
contracts qualify as derivatives requiring separate recognition in our financial
statements. The result of this accounting treatment is that the fair value of
the embedded derivative is revalued as of each reporting date and recorded as a
liability, and the change in fair value during the reporting period is recorded
in other income (expense), net in the Condensed Consolidated Statements of
Operations. In circumstances where the embedded conversion option in a
convertible instrument is required to be bifurcated and there are also other
embedded derivative instruments in the convertible instrument that are required
to be bifurcated, the bifurcated derivative instruments are accounted for as a
single, compound derivative instrument. The classification of derivative
instruments, including whether such instruments should be recorded as
liabilities or as equity, is reassessed at the end of each reporting period.
Derivative instrument liabilities are classified in the Condensed Consolidated
Balance Sheet as current or non-current based on whether or not net-cash
settlement of the derivative instrument is expected within twelve months of the
balance sheet date. When a derivative instrument is sold, terminated, exercised
or expires, the gain or loss is recorded in the Condensed Consolidated
Statements of Operations.

                                       45

--------------------------------------------------------------------------------

Public and Private Placement Warrants



The Company accounts for Public Warrants and Private Placement Warrants as
liability-classified instruments based on an assessment of the warrant's
specific terms and applicable authoritative guidance in FASB ASC 480,
Distinguishing Liabilities from Equity ("ASC 480") and ASC 815, Derivatives and
Hedging ("ASC 815"). Specifically, the exercise of the Public and Private
Placement Warrants may be settled in cash upon the occurrence of a tender offer
or exchange that involves 50% or more of the Company's Class A stockholders.
Because not all of the Company's stockholders need to participate in such tender
offer or exchange to trigger the potential cash settlement and the Company does
not control the occurrence of such an event, the Company concluded that the
Public Warrants and Private Placement Warrants do not meet the conditions to be
classified in equity. Since the Public and Private Placement Warrants meet the
definition of a derivative under ASC 815, the Company recorded these warrants as
liabilities on the balance sheet at fair value upon the closing of the Business
Combination, with subsequent changes in their respective fair values recognized
in the consolidated statement of operations at each reporting date.

Revenue Recognition



Astra adopted the requirements of the new revenue recognition standard, known as
ASC 606, effective January 1, 2020, utilizing the modified retrospective method.
Revenue for Launch Services is recognized at a point in time when the Company
has delivered the promised services to customers.

At contract inception, an assessment of the goods and services promised in the
contracts with customers is expected to be performed and a performance
obligation is identified for each distinct promise to transfer to the customer a
good or service (or bundle of goods or services). To identify the performance
obligations, the Company considers all the goods or services promised in the
contract regardless of whether they are explicitly stated or are implied by
customary business practices.

The transaction price will be defined as the amount of consideration in a
contract to which an entity expects to be entitled in exchange for transferring
promised goods or services to a customer, which is a fixed price stated in the
contract. When a contract involves multiple launches, the Company accounts for
each launch as a separate performance obligation, because the customer can
benefit from each launch on its own or with other readily available resources
and the launch is separately identifiable. The transaction price is allocated to
each performance obligation on an estimated relative standalone selling price
basis. The Company's process to estimate standalone selling prices involves
management's judgment and considers multiple factors such as prices charged for
similar goods and services and the Company's ongoing pricing strategy and
policies.

Changes in judgments with respect to these assumptions and estimates could impact the timing or amount of revenue recognition.

Emerging Growth Company Accounting Election



Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 ("JOBS
Act") exempts emerging growth companies from being required to comply with new
or revised financial accounting standards until private companies are required
to comply with the new or revised financial accounting standards. The JOBS Act
provides that a company can elect not to take advantage of the extended
transition period and comply with the requirements that apply to non-emerging
growth companies, and any such election to not take advantage of the extended
transition period is irrevocable. We are an "emerging growth company" as defined
in Section 2(a) of the Securities Act of 1933, as amended, and has elected to
take advantage of the benefits of this extended transition period and expect to
remain an emerging growth company at least through the end of 2021, thereby
having the benefit of the extended transition period. This may make it difficult
to compare our financial results with the financial results of other public
companies that are either not emerging growth companies or emerging growth
companies that have chosen not to take advantage of the extended transition
period.

Astra will remain an emerging growth company under the JOBS Act until the
earliest of (a) August 7, 2025, the fifth anniversary of our IPO, (b) the last
date of Astra's fiscal year in which it has total annual gross revenue of at
least $1.07 billion, (c) the date on which Astra is deemed to be a "large
accelerated filer" under the rules of the SEC or (d) the date on which Astra has
issued more than $1.0 billion in non-convertible debt securities during the
previous three years.

Recent Accounting Pronouncements



See Note 4 to our condensed consolidated financial statements included elsewhere
in this quarterly report on Form 10-Q for more information about recently
adopted accounting pronouncements and recently issued accounting pronouncements
not yet adopted, including the timing of their adoption, and our assessment, to
the extent we have made one yet, of their potential impact on our financial
condition and our results of operations.

© Edgar Online, source Glimpses